Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Corticosteroids
100%
Clinical Benefit
100%
Inhaled Corticosteroids
100%
Clinical Risk
100%
High Dose
50%
Acute Exacerbation of COPD (AECOPD)
50%
Systemic Corticosteroids
50%
Clinical Trials
25%
Patient Demographics
25%
Hyperglycemia
25%
Forced Expiratory Volume in 1 Second (FEV1)
25%
Respiratory Symptoms
25%
Advanced Disease
25%
Should Be Given
25%
FEV1 Decline
25%
Severe COPD
25%
Serious Adverse Effects
25%
Systemic Steroids
25%
Corticosteroid Therapy
25%
COPD Severity
25%
Systemic Corticosteroid Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Corticosteroid
28%
Clinical Trial
14%
Symptom
14%
Adverse Event
14%
Disease
14%
Hyperglycemia
14%